Copyright: ©Author(s) 2026.
World J Gastroenterol. Sep 7, 2026; 32(33): 118185
Published online Sep 7, 2026. doi: 10.3748/wjg.118185
Published online Sep 7, 2026. doi: 10.3748/wjg.118185
Figure 4 Receiver operating characteristic curves of urinary N1, N12-diacetylspermine combined with serum carcinoembryonic antigen for gastric cancer and colorectal cancer.
A: In gastric cancer patients; B: In colorectal cancer patients. TPR: True positive rate; AUC: Area under the curve; FPR: False positive rate; DiAcSpm: N1, N12-diacetylspermine; CEA: Carcinoembryonic antigen; CI: Confidence interval.
- Citation: Zheng HZ, Wang P, Zheng HJ, Wang ZQ, Li QX, Chen HW, Chen HQ, Lei QC. Urinary N1, N12-diacetylspermine as a potential tumor biomarker for gastric and colorectal cancer. World J Gastroenterol 2026; 32(33): 118185
- URL: https://www.wjgnet.com/1007-9327/full/v32/i33/118185.htm
- DOI: https://dx.doi.org/10.3748/wjg.118185